IonQ Prices $2 Billion Share-And-Warrant Offering, Adding 20.5 Million Shares And 129.5 Million More Possible
The company priced the sale at a combined $40.00, with J.P. Morgan as sole underwriter and delivery expected on or about October 16.
IonQ priced an offering with gross proceeds of about $2.0 billion, selling 20.5 million common shares and 29.5 million pre-funded warrants, each bundled with two Series C warrants, according to a prospectus supplement dated Wednesday. The combined price is $40.00, against a last reported sale price of $34.73 on October 13.
What the prospectus supplement says
Each share, and each pre-funded warrant, comes with two Series C warrants at the combined $40.00. Public proceeds total $1,999,997,050.00, and after $10,000,000.00 in underwriting discounts the company receives $1,989,997,050.00 before expenses. IonQ puts net proceeds at about $1,988.5 million.
The 100 million Series C warrants carry an exercise price of $69.46 a share and run seven years from issuance. The pre-funded warrants exercise at $0.0001 a share, and up to 129.5 million shares can be issued on exercise of the warrants.
The Series C warrants will not be listed on any exchange, and the filing says no public market is expected to develop for them.
The share count and the dilution
IonQ had 408,907,678 shares outstanding as of October 13. After the offering it will have 429,407,678, a count that leaves out the warrants. The 20.5 million new shares are about 4.8% of that post-offering total. If all warrants were exercised, the count would reach 558,907,678.
Investors buying at $40.00 face immediate dilution of $34.52 a share, the filing says. Net tangible book value was $0.98 a share on June 30, and the company calculates $5.48 a share as adjusted for the offering.
The company said it intends to use the proceeds, together with existing cash, "for working capital and other general corporate purposes." It adds that a portion may go to strategic acquisitions and partnerships.
Losses and pending deals
Losses from operations were $608.8 million for the six months ended June 30, 2026, versus $236.3 million a year earlier. The accumulated deficit stood at $2,256.5 million on June 30.
IonQ completed its SkyWater Technology acquisition on July 31. On October 9 it signed a merger agreement for Elisity, with closing consideration in stock valued at $1.15 billion and up to $150 million more in shares if revenue milestones are met. That deal remains subject to regulatory approvals.
What to watch
IonQ expects to deliver the shares and warrants on or about October 16. Directors and officers have signed 30-day lock-up agreements with J.P. Morgan, subject to certain exceptions.
The filing also flags two material weaknesses in financial-reporting controls that IonQ assumed with SkyWater, which it says it has not yet concluded are remediated.
Sources
- Form 424B5 — IonQ, Inc. (IONQ) — SEC EDGAR
- IonQ to Acquire Elisity to Accelerate Zero Trust for the Quantum Era | Nasdaq — nasdaq.com
- IonQ Stock Fell 9% as Investors Weighed Up to $1.3 Billion in New Shares. Here’s What It Means for Holders — Yahoo Finance
- IonQ Stock Falls On $1.3 Billion Elisity Deal As Quantum Acquisition Spree Continues | Investor's Business Daily — investors.com
- A $1.3 Billion Reason Why IONQ Stock Is Down Today — Yahoo Finance